Simplex Trading, LLC Nkarta, Inc. Transaction History

Simplex Trading, LLC

$175 Billion
Q2 2025

A detailed history of Simplex Trading, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 5,064 shares of NKTX stock, worth $9,925. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,064

Previous 37,239 86.4%

Holding current value

$9,925

Previous $68,000 88.24%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$1.51 - $2.22 $48,584 - $71,428	-32,175 Reduced 86.4%	5,064 $8,000
Q1 2025 May 12, 2025	SELL	$1.37 - $2.53 $229,824 - $424,420	-167,755 Reduced 81.83%	37,239 $68,000
Q4 2024 Feb 11, 2025	BUY	$2.17 - $4.34 $439,340 - $878,680	202,461 Added 7992.93%	204,994 $510,000
Q3 2024 Nov 08, 2024	SELL	$4.52 - $8.0 $23,142 - $40,960	-5,120 Reduced 66.9%	2,533 $11,000
Q2 2024 Jul 25, 2024	BUY	$5.27 - $10.82 $40,331 - $82,805	7,653 New	7,653 $45,000
Q4 2023 Feb 02, 2024	BUY	$1.31 - $6.6 $8,648 - $43,573	6,602 Added 58.55%	17,877 $117,000
Q3 2023 Nov 01, 2023	BUY	$1.39 - $2.29 $8,645 - $14,243	6,220 Added 123.05%	11,275 $15,000
Q2 2023 Aug 04, 2023	BUY	$2.19 - $5.17 $7,601 - $17,945	3,471 Added 219.13%	5,055 $11,000
Q1 2023 Apr 27, 2023	SELL	$3.37 - $6.3 $2,086 - $3,899	-619 Reduced 28.1%	1,584 $5,000
Q4 2022 Feb 02, 2023	BUY	$5.14 - $14.35 $11,323 - $31,613	2,203 New	2,203 $13,000
Q2 2022 Aug 03, 2022	SELL	$7.77 - $19.44 $17,086 - $42,748	-2,199 Reduced 25.1%	6,561 $80,000
Q1 2022 May 02, 2022	BUY	$8.66 - $14.99 $64,032 - $110,836	7,394 Added 541.29%	8,760 $99,000
Q3 2021 Oct 28, 2021	BUY	$26.67 - $38.76 $5,334 - $7,752	200 Added 17.15%	1,366 $41,000
Q2 2021 Aug 12, 2021	BUY	$23.94 - $36.68 $27,914 - $42,768	1,166 New	1,166 $36,000

Others Institutions Holding NKTX

# of Institutions

119

Shares Held

61.5M

Call Options Held

13.7K

Put Options Held

10.3K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $95.4M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Nkarta, Inc. Transaction History